close to approving another new drug for obesity

The FDA is getting close to approving another new drug for obesity...Meridia (sibutramine) from Knoll.

Meridia is a serotonin AND norepinephrine reuptake inhibitor. It's in the same class as the antidepressant Effexor (venlafaxine).

In fact, Meridia was originally being developed as an antidepressant. The manufacturer switched gears when they noticed that it causes weight loss. The weight loss market is a lot less crowded than the antidepressant market.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote